270 related articles for article (PubMed ID: 3008430)
1. An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine.
Kohara M; Abe S; Kuge S; Semler BL; Komatsu T; Arita M; Itoh H; Nomoto A
Virology; 1986 May; 151(1):21-30. PubMed ID: 3008430
[TBL] [Abstract][Full Text] [Related]
2. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS
Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271
[TBL] [Abstract][Full Text] [Related]
3. Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus.
Omata T; Kohara M; Sakai Y; Kameda A; Imura N; Nomoto A
Gene; 1984 Dec; 32(1-2):1-10. PubMed ID: 6099306
[TBL] [Abstract][Full Text] [Related]
4. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.
Kohara M; Omata T; Kameda A; Semler BL; Itoh H; Wimmer E; Nomoto A
J Virol; 1985 Mar; 53(3):786-92. PubMed ID: 2983090
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of the attenuation phenotype of poliovirus type 1.
Omata T; Kohara M; Kuge S; Komatsu T; Abe S; Semler BL; Kameda A; Itoh H; Arita M; Wimmer E
J Virol; 1986 May; 58(2):348-58. PubMed ID: 3009852
[TBL] [Abstract][Full Text] [Related]
6. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
[TBL] [Abstract][Full Text] [Related]
7. Non-neurovirulent, genetically stable clone of poliovirus (Sabin type III vaccine strain).
Ubertini TR; Cioni C; Perini L; Gagnoni S
Vaccine; 1988 Dec; 6(6):481-2. PubMed ID: 2854337
[TBL] [Abstract][Full Text] [Related]
8. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.
Kawamura N; Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1989 Mar; 63(3):1302-9. PubMed ID: 2536835
[TBL] [Abstract][Full Text] [Related]
9. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.
Rezapkin GV; Norwood LP; Taffs RE; Dragunsky EM; Levenbook IS; Chumakov KM
Virology; 1995 Aug; 211(2):377-84. PubMed ID: 7645242
[TBL] [Abstract][Full Text] [Related]
10. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
11. Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine.
Rezapkin GV; Chumakov KM; Lu Z; Ran Y; Dragunsky EM; Levenbook IS
Virology; 1994 Jul; 202(1):370-8. PubMed ID: 8009849
[TBL] [Abstract][Full Text] [Related]
12. Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome.
Iizuka N; Kohara M; Hagino-Yamagishi K; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1989 Dec; 63(12):5354-63. PubMed ID: 2555560
[TBL] [Abstract][Full Text] [Related]
13. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
[TBL] [Abstract][Full Text] [Related]
14. The effect of serial passage on Sabin oral poliomyelitis vaccine virus in secondary monkey kidney versus Vero cells as measured by the monkey neurovirulence test.
Dommann CJ
J Med Primatol; 1994 Sep; 23(7):388-92. PubMed ID: 7731028
[TBL] [Abstract][Full Text] [Related]
15. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
Kohara M; Abe S; Yoshioka I; Nomoto A
Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824
[TBL] [Abstract][Full Text] [Related]
16. Strategy for construction of live picornavirus vaccines.
Nomoto A; Iizuka N; Kohara M; Arita M
Vaccine; 1988 Apr; 6(2):134-7. PubMed ID: 2838985
[TBL] [Abstract][Full Text] [Related]
17. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.
Bouchard MJ; Lam DH; Racaniello VR
J Virol; 1995 Aug; 69(8):4972-8. PubMed ID: 7609067
[TBL] [Abstract][Full Text] [Related]
18. Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.
Georgescu MM; Tardy-Panit M; Guillot S; Crainic R; Delpeyroux F
J Virol; 1995 Sep; 69(9):5278-86. PubMed ID: 7636970
[TBL] [Abstract][Full Text] [Related]
19. Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.
Pliaka V; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonika C; Levidiotou-Stefanou S; Krikelis A; Markoulatos P
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1513-23. PubMed ID: 20820837
[TBL] [Abstract][Full Text] [Related]
20. Genetic stability of Sabin 1 strain of poliovirus: implications for quality control of oral poliovirus vaccine.
Rezapkin GV; Alexander W; Dragunsky E; Parker M; Pomeroy K; Asher DM; Chumakov KM
Virology; 1998 Jun; 245(2):183-7. PubMed ID: 9636357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]